In the tumor immune microenvironment, CD8 + T cells differentiate towards functional failure. The exhaustion of CD8 + T cells (Tex) showed varying degrees of effect dysfunction, loss of proliferation ability, and sustained high expression of a variety of inhibitory receptors, with metabolic and epigenetic changes. Tex cells are heterogeneous, including several subsets with different characteristics at different stages of differentiation. Immune checkpoint inhibitors (ICIs) can restore the effect or function of Tex cells, indicating that this T cell subset plays a key role in tumor immunotherapy. The understanding of the mechanism of CD8 + T cell exhaustion will be helpful to the implementation of tumor immunotherapy. This article reviews the production, differentiation and functional characteristics of Tex cells and their relationship with tumor immunotherapy.
Henning, A.N., Roychoudhuri, R. and Restifo, N.P. (2018) Epigenetic Control of CD8+ T Cell Differentiation. Nature Reviews Immunology, 18, 340-356. https://doi.org/10.1038/nri.2017.146
Montacchiesi, G. and Pace, L. (2022) Epigenetics and CD8+ T Cell Memory. Immunology Research, 305, 77-89. https://doi.org/10.1111/imr.13057
Schietinger, A., Philip, M., Krisnawan, V.E., et al. (2016) Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis. Immunity, 45, 389-401. https://doi.org/10.1016/j.immuni.2016.07.011
Hellstrom, K.E. and Hellstrom, I. (2019) From the Hellstrom Paradox toward Cancer Cure. Progress in Molecular Biology and Translational Science, 164, 1-24. https://doi.org/10.1016/bs.pmbts.2018.11.002
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., et al. (2019) Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. The New England Journal of Medicine, 381, 1535-1546. https://doi.org/10.1056/NEJMoa1910836
Mamdani, H., Matosevic, S., Khalid, A.B., Durm, G. and Jalal, S.I. (2022) Immunotherapy in Lung Cancer: Current Landscape and Future Directions. Frontiers in Immunology, 13, Article ID: 823618. https://doi.org/10.3389/fimmu.2022.823618
Miller, B.C., Sen, D.R., Al Abosy, R., et al. (2019) Subsets of Exhausted CD8+ T Cells Differentially Mediate Tumor Control and Respond to Checkpoint Blockade [Published Correction Appears in Nat Immunol. 2019 Nov; 20(11): 1556]. Nature Immunology, 20, 326-336. https://doi.org/10.1038/s41590-019-0312-6
Zajac, A.J., Blattman, J.N., Murali-Krishna, K., et al. (1998) Viral Immune Evasion Due to Persistence of Activated T Cells without Effector Function. Journal of Experimental Medicine, 188, 2205-2213. https://doi.org/10.1084/jem.188.12.2205
Fenwick, C., Joo, V., Jacquier, P., et al. (2019) T-Cell Exhaustion in HIV Infection. Immunology Research, 292, 149-163. https://doi.org/10.1111/imr.12823
Baudi, I., Kawashima, K. and Isogawa, M. (2021) HBV-Specific CD8+ T-Cell Tolerance in the Liver. Frontiers in Immunology, 12, Article ID: 721975. https://doi.org/10.3389/fimmu.2021.721975
Hofmann, M., Tauber, C., Hensel, N. and Thimme, R. (2021) CD8+ T Cell Responses during HCV Infection and HCC. Journal of Clinical Medicine, 10, 991. https://doi.org/10.3390/jcm10050991
Knapp, S., Hennig, B.J., Frodsham, A.J., et al. (2003) Interleukin-10 Promoter Polymorphisms and the Outcome of Hepatitis C Virus Infection. Immunogenetics, 55, 362-369. https://doi.org/10.1007/s00251-003-0594-5
Tinoco, R., Alcalde, V., Yang, Y., Sauer, K. and Zuniga, E.I. (2009) Cell-Intrinsic Transforming Growth Factor-Beta Signaling Mediates Virus-Specific CD8+ T Cell Deletion and Viral Persistence in Vivo. Immunity, 31, 145-157. https://doi.org/10.1016/j.immuni.2009.06.015
Bachmann, M.F., Wolint, P., Walton, S., Schwarz, K. and Oxenius, A. (2007) Differential Role of IL-2R Signaling for CD8+ T Cell Responses in Acute and Chronic Viral Infections. European Journal of Immunology, 37, 1502-1512. https://doi.org/10.1002/eji.200637023
Fröhlich, A., Kisielow, J., Schmitz, I., et al. (2009) IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection. Science, 324, 1576-1580. https://doi.org/10.1126/science.1172815
van der Leun, A.M., Thommen, D.S. and Schumacher, T.N. (2020) CD8+ T Cell States in Human Cancer: Insights from Single-Cell Analysis. Nature Reviews Cancer, 20, 218-232. https://doi.org/10.1038/s41568-019-0235-4
Philip, M., Fairchild, L., Sun, L., et al. (2017) Chromatin States Define Tumour-Specific T Cell Dysfunction and Reprogramming. Nature, 545, 452-456. https://doi.org/10.1038/nature22367
Pauken, K.E., Sammons, M.A., Odorizzi, P.M., et al. (2016) Epigenetic Stability of Exhausted T Cells Limits Durability of Reinvigoration by PD-1 Blockade. Science, 354, 1160-1165. https://doi.org/10.1126/science.aaf2807
Beltra, J.C., Manne, S., Abdel-Hakeem, M.S., et al. (2020) Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms. Immunity, 52, 825-841.e8. https://doi.org/10.1016/j.immuni.2020.04.014
McLane, L.M., Abdel-Hakeem, M.S. and Wherry, E.J. (2019) CD8 T Cell Exhaustion during Chronic Viral Infection and Cancer. Annual Review of Immunology, 37, 457-495. https://doi.org/10.1146/annurev-immunol-041015-055318
Wherry, E.J., Blattman, J.N., Murali-Krishna, K., van der Most, R. and Ahmed, R. (2003) Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment. Journal of Virology, 77, 4911-4927. https://doi.org/10.1128/JVI.77.8.4911-4927.2003
Reina-Campos, M., Scharping, N.E. and Goldrath, A.W. (2021) CD8+ T Cell Metabolism in Infection and Cancer. Nature Reviews Immunology, 21, 718-738. https://doi.org/10.1038/s41577-021-00537-8
Marasco, M., Berteotti, A., Weyershaeuser, J., et al. (2020) Molecular Mechanism of SHP2 Activation by PD-1 Stimulation. Science Advances, 6, eaay4458. https://doi.org/10.1126/sciadv.aay4458
Patsoukis, N., Bardhan, K., Chatterjee, P., et al. (2015) PD-1 Alters T-Cell Metabolic Reprogramming by Inhibiting Glycolysis and Promoting Lipolysis and Fatty Acid Oxidation. Nature Communications, 6, 6692. https://doi.org/10.1038/ncomms7692
Spranger, S., Bao, R. and Gajewski, T.F. (2015) Melanoma-Intrinsic β-Catenin Signalling Prevents Anti-Tumour Immunity. Nature, 523, 231-235. https://doi.org/10.1038/nature14404
de Miguel, M. and Calvo, E. (2020) Clinical Challenges of Immune Checkpoint Inhibitors. Cancer Cell, 38, 326-333. https://doi.org/10.1016/j.ccell.2020.07.004
Zheng, J., Huang, B., Xiao, L., Wu, M. and Li, J. (2022) Treatment- and Immune- Related Adverse Events of Immune Checkpoint Inhibitors in Esophageal or Gastroesophageal Junction Cancer: A Network Meta-Analysis of Randomized Controlled Trials. Frontiers in Oncology, 12, Article ID: 821626. https://doi.org/10.3389/fonc.2022.821626
Gu, J., Shi, L., Jiang, X., et al. (2022) Severe Immune-Related Adverse Events of Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: A Network Meta-Analysis of Randomized Clinical Trials. Cancer Immunology, Immunotherapy, 71, 2239-2254. https://doi.org/10.1007/s00262-022-03140-5